{"resourceType":"CodeSystem","id":"ssf-1-leukemia-codesystem","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>https://hapi.fhir.tw/fhir/CodeSystem/ssf-1-leukemia-codesystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">000<a name=\"ssf-1-leukemia-codesystem-000\"> </a></td><td>正常</td></tr><tr><td style=\"white-space:nowrap\">001<a name=\"ssf-1-leukemia-codesystem-001\"> </a></td><td>AML with t(8;21)(q22;q22.1</td></tr><tr><td style=\"white-space:nowrap\">002<a name=\"ssf-1-leukemia-codesystem-002\"> </a></td><td>AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)</td></tr><tr><td style=\"white-space:nowrap\">003<a name=\"ssf-1-leukemia-codesystem-003\"> </a></td><td>Acute promyelocytic leukemia with t(15;17)</td></tr><tr><td style=\"white-space:nowrap\">004<a name=\"ssf-1-leukemia-codesystem-004\"> </a></td><td>AML with t(9;11)(p21.3;q23.3)</td></tr><tr><td style=\"white-space:nowrap\">005<a name=\"ssf-1-leukemia-codesystem-005\"> </a></td><td>AML with t(6;9)(p23;q34.1)</td></tr><tr><td style=\"white-space:nowrap\">006<a name=\"ssf-1-leukemia-codesystem-006\"> </a></td><td>AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)</td></tr><tr><td style=\"white-space:nowrap\">007<a name=\"ssf-1-leukemia-codesystem-007\"> </a></td><td>AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)</td></tr><tr><td style=\"white-space:nowrap\">013<a name=\"ssf-1-leukemia-codesystem-013\"> </a></td><td>AML with t(9;22)(q34;q11)</td></tr><tr><td style=\"white-space:nowrap\">021<a name=\"ssf-1-leukemia-codesystem-021\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)</td></tr><tr><td style=\"white-space:nowrap\">022<a name=\"ssf-1-leukemia-codesystem-022\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(v;11q23.3)</td></tr><tr><td style=\"white-space:nowrap\">023<a name=\"ssf-1-leukemia-codesystem-023\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)</td></tr><tr><td style=\"white-space:nowrap\">024<a name=\"ssf-1-leukemia-codesystem-024\"> </a></td><td>B lymphoblastic leukemia / lymphoma with hyperdiploidy</td></tr><tr><td style=\"white-space:nowrap\">025<a name=\"ssf-1-leukemia-codesystem-025\"> </a></td><td>B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)</td></tr><tr><td style=\"white-space:nowrap\">026<a name=\"ssf-1-leukemia-codesystem-026\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)</td></tr><tr><td style=\"white-space:nowrap\">027<a name=\"ssf-1-leukemia-codesystem-027\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)</td></tr><tr><td style=\"white-space:nowrap\">041<a name=\"ssf-1-leukemia-codesystem-041\"> </a></td><td>Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)</td></tr><tr><td style=\"white-space:nowrap\">042<a name=\"ssf-1-leukemia-codesystem-042\"> </a></td><td>Mixed phenotype acute leukemia with t(v;11q23.3)</td></tr><tr><td style=\"white-space:nowrap\">051<a name=\"ssf-1-leukemia-codesystem-051\"> </a></td><td>Chronic myelogenous leukemia，t(9;22)</td></tr><tr><td style=\"white-space:nowrap\">061<a name=\"ssf-1-leukemia-codesystem-061\"> </a></td><td>Myelodysplastic syndrome associated with isolated del(5q-)</td></tr><tr><td style=\"white-space:nowrap\">090<a name=\"ssf-1-leukemia-codesystem-090\"> </a></td><td>(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常</td></tr><tr><td style=\"white-space:nowrap\">091<a name=\"ssf-1-leukemia-codesystem-091\"> </a></td><td>同時有兩種上述之染色體異常</td></tr><tr><td style=\"white-space:nowrap\">092<a name=\"ssf-1-leukemia-codesystem-092\"> </a></td><td>複雜之染色體異常，指三項(含)以上的染色體變化者</td></tr><tr><td style=\"white-space:nowrap\">8XX<a name=\"ssf-1-leukemia-codesystem-8XX\"> </a></td><td>Chromosome study after chemotherapy or immunotherapy or target therapy</td></tr><tr><td style=\"white-space:nowrap\">988<a name=\"ssf-1-leukemia-codesystem-988\"> </a></td><td>不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)</td></tr><tr><td style=\"white-space:nowrap\">998<a name=\"ssf-1-leukemia-codesystem-998\"> </a></td><td>有執行染色體檢查，但結果無法判斷</td></tr><tr><td style=\"white-space:nowrap\">999<a name=\"ssf-1-leukemia-codesystem-999\"> </a></td><td>病歷未記載或不詳或未執行染色體檢查</td></tr></table></div>"},"url":"https://hapi.fhir.tw/fhir/CodeSystem/ssf-1-leukemia-codesystem","version":"0.1.0","name":"SSF1leukemiaCS","title":"SSF1 白血病-白血病染色體檢查的評估","status":"draft","experimental":false,"date":"2023-09-26T09:09:58+08:00","publisher":"Kuo","contact":[{"name":"Kuo","telecom":[{"system":"url","value":"http://example.org/example-publisher"}]}],"description":"Assessment of chromosome study in leukemia Code System","caseSensitive":true,"content":"complete","count":27,"concept":[{"code":"000","display":"正常"},{"code":"001","display":"AML with t(8;21)(q22;q22.1"},{"code":"002","display":"AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)"},{"code":"003","display":"Acute promyelocytic leukemia with t(15;17)"},{"code":"004","display":"AML with t(9;11)(p21.3;q23.3)"},{"code":"005","display":"AML with t(6;9)(p23;q34.1)"},{"code":"006","display":"AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)"},{"code":"007","display":"AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)"},{"code":"013","display":"AML with t(9;22)(q34;q11)"},{"code":"021","display":"B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)"},{"code":"022","display":"B lymphoblastic leukemia / lymphoma with t(v;11q23.3)"},{"code":"023","display":"B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)"},{"code":"024","display":"B lymphoblastic leukemia / lymphoma with hyperdiploidy"},{"code":"025","display":"B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)"},{"code":"026","display":"B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)"},{"code":"027","display":"B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)"},{"code":"041","display":"Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)"},{"code":"042","display":"Mixed phenotype acute leukemia with t(v;11q23.3)"},{"code":"051","display":"Chronic myelogenous leukemia，t(9;22)"},{"code":"061","display":"Myelodysplastic syndrome associated with isolated del(5q-)"},{"code":"090","display":"(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常"},{"code":"091","display":"同時有兩種上述之染色體異常"},{"code":"092","display":"複雜之染色體異常，指三項(含)以上的染色體變化者"},{"code":"8XX","display":"Chromosome study after chemotherapy or immunotherapy or target therapy"},{"code":"988","display":"不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)"},{"code":"998","display":"有執行染色體檢查，但結果無法判斷"},{"code":"999","display":"病歷未記載或不詳或未執行染色體檢查"}]}